---
figid: PMC7784492__MCS005629Xu_F3
figlink: pmc/articles/PMC7784492/figure/MCS005629XUF3/
number: Figure 3
caption: Pathways affected by mutations. DNA-based analysis from solid tumors revealed
  multiple somatic mutations in the PI3K–Akt signaling pathway (PIK3CA, PIK3R1, PTEN,
  MTOR) across all samples. Other mutations were detected in both solid and liquid
  samples, affecting RAS–RAF, cell cycle, and other critical pathways regulating apoptosis
  and cell proliferation. Germline variant FGFR4 p.G388R was detected. It creates
  an additional binding site for STAT3 at the cell membrane so it can be phosphorylated
  without upstream signals from preclinical studies. If the above conclusion holds
  true in this patient, the activated STAT3 might have established a resistance mechanism
  for treatment targeting the PI3K-mTOR pathway.
pmcid: PMC7784492
papertitle: 'Case report: 16-yr life history and genomic evolution of an ER+ HER2−
  breast cancer.'
reftext: Bing Xu, et al. Cold Spring Harb Mol Case Stud. 2020 Dec;6(6):a005629.
pmc_ranked_result_index: '5817'
pathway_score: 0.9707363
filename: MCS005629Xu_F3.jpg
figtitle: Pathways affected by mutations
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7784492__MCS005629Xu_F3.html
  '@type': Dataset
  description: Pathways affected by mutations. DNA-based analysis from solid tumors
    revealed multiple somatic mutations in the PI3K–Akt signaling pathway (PIK3CA,
    PIK3R1, PTEN, MTOR) across all samples. Other mutations were detected in both
    solid and liquid samples, affecting RAS–RAF, cell cycle, and other critical pathways
    regulating apoptosis and cell proliferation. Germline variant FGFR4 p.G388R was
    detected. It creates an additional binding site for STAT3 at the cell membrane
    so it can be phosphorylated without upstream signals from preclinical studies.
    If the above conclusion holds true in this patient, the activated STAT3 might
    have established a resistance mechanism for treatment targeting the PI3K-mTOR
    pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGFR4
  - HRAS
  - KRAS
  - NRAS
  - SART3
  - AKT2
  - AKT3
  - AKT1
  - NF1
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - PTEN
  - ARAF
  - BRAF
  - RAF1
  - MAP2K2
  - STAT3
  - MAPK3
  - CDK2
  - CDK4
  - CDK6
  - E2F3
  - E2F8
  - E2F1
  - E2F2
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - TP53
genes:
- word: FGFR4
  symbol: FGFR4
  source: hgnc_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: NF1
  symbol: NF1
  source: hgnc_symbol
  hgnc_symbol: NF1
  entrez: '4763'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: (MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: (ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: /CDK2
  symbol: CDK2
  source: hgnc_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: CyclinE/CDK2
  symbol: CDK2
  source: hgnc_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: /CDK4/6
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: /CDK4/6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
- word: р53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
chemicals: []
diseases: []
---
